Formulation and evaluation of baclofen-meloxicam orally disintegrating tablets (ODTs) using co-processed excipients and improvement of ODTs performance using …

R Abdelmonem, MM Abdellatif… - Drug Design …, 2021 - Taylor & Francis
Purpose This study aimed to formulate an orally disintegrating tablet (ODT) containing both
baclofen and meloxicam together for treating osteoarthritis. Methods Direct compression …

Formulation and Evaluation of Baclofen-Meloxicam Orally Disintegrating Tablets (ODTs) Using Co-Processed Excipients and Improvement of ODTs Performance …

R Abdelmonem, MM Abdellatif… - Drug Design …, 2021 - dovepress.com
Purpose: This study aimed to formulate an orally disintegrating tablet (ODT) containing both
baclofen and meloxicam together for treating osteoarthritis. Methods: Direct compression …

[HTML][HTML] Formulation and Evaluation of Baclofen-Meloxicam Orally Disintegrating Tablets (ODTs) Using Co-Processed Excipients and Improvement of ODTs …

R Abdelmonem, MM Abdellatif… - Drug Design …, 2021 - ncbi.nlm.nih.gov
Purpose This study aimed to formulate an orally disintegrating tablet (ODT) containing both
baclofen and meloxicam together for treating osteoarthritis. Methods Direct compression …

Formulation and Evaluation of Baclofen-Meloxicam Orally Disintegrating Tablets (ODTs) Using Co-Processed Excipients and Improvement of ODTs Performance …

R Abdelmonem, MM Abdellatif… - Drug Design …, 2021 - europepmc.org
Purpose This study aimed to formulate an orally disintegrating tablet (ODT) containing both
baclofen and meloxicam together for treating osteoarthritis. Methods Direct compression …

[PDF][PDF] Formulation and Evaluation of Baclofen-Meloxicam Orally Disintegrating Tablets (ODTs) Using Co-Processed Excipients and Improvement of ODTs …

R Abdelmonem, MM Abdellatif… - Drug Design …, 2021 - pdfs.semanticscholar.org
Purpose: This study aimed to formulate an orally disintegrating tablet (ODT) containing both
baclofen and meloxicam together for treating osteoarthritis. Methods: Direct compression …

Formulation and Evaluation of Baclofen-Meloxicam Orally Disintegrating Tablets (ODTs) Using Co-Processed Excipients and Improvement of ODTs Performance …

R Abdelmonem, MM Abdellatif… - Drug Design …, 2021 - search.proquest.com
Purpose: This study aimed to formulate an orally disintegrating tablet (ODT) containing both
baclofen and meloxicam together for treating osteoarthritis. Methods: Direct compression …

Formulation and Evaluation of Baclofen-Meloxicam Orally Disintegrating Tablets (ODTs) Using Co-Processed Excipients and Improvement of ODTs Performance …

R Abdelmonem, MM Abdellatif… - Drug design …, 2021 - pubmed.ncbi.nlm.nih.gov
Purpose This study aimed to formulate an orally disintegrating tablet (ODT) containing both
baclofen and meloxicam together for treating osteoarthritis. Methods Direct compression …

[PDF][PDF] Formulation and Evaluation of Baclofen-Meloxicam Orally Disintegrating Tablets (ODTs) Using Co-Processed Excipients and Improvement of ODTs …

R Abdelmonem, MM Abdellatif, IE Ibrahim… - Drug Design …, 2021 - scienceopen.com
Purpose: This study aimed to formulate an orally disintegrating tablet (ODT) containing both
baclofen and meloxicam together for treating osteoarthritis. Methods: Direct compression …

[引用][C] Formulation and Evaluation of Baclofen-Meloxicam Orally Disintegrating Tablets (ODTs) Using Co-Processed Excipients and Improvement of ODTs …

R Abdelmonem, MM Abdellatif, IEI Al-Samadi…